Private Market View

Bodhi Tree Biotechnology

Danville, CA · Founded 2023 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$50K
Last round

Key facts

  • It has raised $50K; the latest was Angel (individual) ($50K) in Jun 2025.
  • Bodhi Tree Biotechnology has filed 2 Form Ds with the SEC, most recently Jun 2025 ($48K sold to 32 investors).
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·Watchlist + deal alerts for Bodhi Tree Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Bodhi Tree Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Bodhi Tree Biotechnology

Producer of plant-based food products intended to promote healthier lifestyles and environmental sustainability. The company specializes in biotechnology-driven vegetarian meal development, recipe creation, and sustainable sourcing, enabling health-conscious consumers to access fresh, nutritious, and environmentally friendly food options that support well-being and respect for nature.

Sector
Consumer Products and Services (B2C)
HQ
Danville, CA, United States
Founded
2023
Ownership
Privately Held (backing)
PA Mark — not yet priced

Bodhi Tree Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Bodhi Tree Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Bodhi Tree Biotechnology in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.